Diabetes

How leptin, the 'satiety hormone,' reverses diabetes

(Medical Xpress)—Treatment with leptin, the hormone associated with fullness or satiety, reverses hyperglycemia in animals models of poorly controlled type 1 (T1D) and type 2 (T2D) diabetes by suppressing the neuroendocrine ...

Diabetes

G-pen may aid hypoglycemia with type 1 diabetes

(HealthDay)—Mini-dose glucagon administered using a stable, ready-to-use G-Pen Mini glucagon may be an effective option for mild to moderate hypoglycemia in adults with type 1 diabetes, according to a study published online ...

Diabetes

Sensors to simplify diabetes management

For many patients diagnosed with diabetes, treating the disease can mean a burdensome and uncomfortable lifelong routine of monitoring blood sugar levels and injecting the insulin that their bodies don't naturally produce. ...

Diabetes

Vildagliptin, sitagliptin have similar effects on incretin

(HealthDay)—The dipeptidyl peptidase-4 (DPP-4) inhibitors vildagliptin and sitagliptin have similar effects on incretin hormone secretion, according to a study published online June 14 in Diabetes, Obesity and Metabolism.

Neuroscience

Poor diet can cause Alzheimer's or Parkinson's in rats

For several years, a researcher fed rodents in his laboratory a high caloric diet with glucose concentrations, which resulted in diabetes. By scientifically assessing what occurred in rats, Samuel Treviño Mora from the Meritorious ...

Diabetes

Sucralose affects response to oral glucose load in obese

(HealthDay)—For obese adults who do not use non-nutritive sweetener (NNS), sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in Diabetes Care.

page 1 from 3